New PHIL Research on the Future of Pharma DTP: 3 in 4 Leaders Report Direct-to-Patient a Major Strategic Priority Today, Growing 20% in “Mission Critical” Significance in 2027
SCOTTSDALE, Ariz.--(BUSINESS WIRE)--A new research survey of 74 U.S. life sciences leaders finds direct-to-patient's mission-critical urgency is rising.